Open Access

Single-pill combinations (SPCs) first line in ESC/ESH 2018 guidelines for hypertensive patients: where do we stand 3 years later?

Event: ESC Congress 2021 - The Digital Experience
Topic: Hypertension
Session type: Satellite Symposium
Sponsored by Servier
Date: 29 August 2021
Time: 13:00 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Introduction.

Speaker: Professor A. Januszewicz (Warsaw, PL)
Thumbnail

Dual therapy, triple therapy, or single-pill combination: still underused or already part of physicians' mindsets?

Speaker: Professor A. Pathak (Monaco, MC)
Thumbnail

Following current guidelines, and beyond, Single-pill combinations (SPC) is a way to improve patient care in hypertension.

Speaker: Doctor O. Rotar (Saint Petersburg, RU)
Thumbnail

Conclusion.

Speaker: Professor K. Tsioufis (Athens, GR)
Thumbnail

4 speakers from this session

Professor Andrzej Januszewicz

Institute of Cardiology, Warsaw (Poland)
1 presentation
1 follower

Professor Atul Pathak

The Princess Grace Hospital Centre, Monaco (Monaco)
14 presentations
0 follower

Doctor Oxana Rotar

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
4 presentations
1 follower

Professor Konstantinos Tsioufis

Hippokration General Hospital, Athens (Greece)
22 presentations
1 follower

Related content

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk